Clinical trial Recruiting at 1 site Observational Ages 18 to 99

Evaluating activity levels in patients receiving bone marrow transplants

Official title: Activity Levels in Bone Marrow Transplant Patients

Run by University of Iowa · NCT04115241 · Data updated 2026-11-12

This study looks at how active people are before and after bone marrow transplants to see if it affects their recovery, hospital stay, and overall well-being.

Quick facts

Study typeObservational
Ages18 Years to 99 Years
SexAll
Enrollment200 (estimated)
SponsorUniversity of Iowa
Academic / other
Locations1 site (Iowa City, Iowa)
StatusRecruiting
StartedMay 23, 2019
Main results expectedMay 23, 2030
Study endsMay 23, 2030
Registry record updatedNovember 10, 2025
Trial IDNCT04115241 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients scheduled to receive a bone marrow transplant.

Probably not a fit

Patients who are not undergoing a bone marrow transplant will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients undergoing bone marrow transplants to assess how their activity levels relate to their length of hospital stay, quality of life, and hand grip strength. Participants will wear actigraphs to monitor their activity from three weeks prior to the transplant until discharge. Additionally, they will complete quality of life questionnaires and undergo hand grip tests at various points during their hospitalization. The collected data will help establish correlations between physical activity and recovery outcomes.

Why it matters

Potential benefit: If successful, this study could provide insights into how increased activity levels may improve recovery and quality of life for bone marrow transplant patients.

How similar studies have gone: While there may be related studies, this specific approach of correlating activity levels with recovery metrics in bone marrow transplant patients is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Patients who will be receiving a bone marrow transplant are eligible for this study

Where it's running

  • University of Iowa
    Iowa City, Iowa, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Cardiovascular health in children and young adults with chronic conditions

    This project will see if children and young adults (ages 6-25) with chronic health conditions show early signs of aging in large and small blood vessels using noninvasive imaging and clinical tests.

    Recruiting Semmelweis University · Budapest and 2 other locations · NCT07086989

  • Improving outcomes for stem cell transplant patients using an intervention website

    This study is testing if a special website can help adults with blood cancer feel better and improve their quality of life after a stem cell transplant compared to a regular educational website.

    Recruiting at 3 sites Northwestern University · Washington D.C., District of Columbia and 2 other locations · NCT06960993

  • Evaluating Shingrix Vaccine in Stem Cell Transplant Recipients

    This study tests if the Shingrix vaccine is safe and effective for people who have had a stem cell transplant, and looks at how the timing of the vaccine affects their immune response.

    Recruiting Phase 2 University of Colorado, Denver · Aurora, Colorado · NCT05775718

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.